TFA
TXMD icon

Tobias Financial Advisors’s TherapeuticsMD TXMD Stock Holding History

Tobias Financial Advisors’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-320
Closed -$6K – 90
2022
Q1 		$6K Buy
+320
New +$5.03K ﹤0.01% 76
2021
Q4 		– Sell
-320
Closed -$12K – 114
2021
Q3 		$12K Buy
+320
New +$14.2K ﹤0.01% 69
2020
Q1 		– Sell
-80
Closed -$9K – 269
2019
Q4 		$9K Buy
+80
New +$11.5K 0.01% 191

Other funds holding TXMD

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

Tobias Financial Advisors's TXMD Position: Q2 2022 in Review

Tobias Financial Advisors sold out of TherapeuticsMD (TXMD) in Q2 2022, closing a stake of 320 shares — an estimated $6K sold.

Tobias Financial Advisors first reported a position in TXMD in Q4 2019 and held it in 3 quarters. The position peaked at $12K in Q3 2021. 53 funds tracked by Wall St. Rank hold TXMD as of Q2 2022.

  • Tobias Financial Advisors reported no remaining TherapeuticsMD position as of Q2 2022 after selling out during the quarter.
  • Tobias Financial Advisors sold 320 TherapeuticsMD shares in Q2 2022, an estimated $6K.
  • Tobias Financial Advisors first reported a position in TherapeuticsMD in Q4 2019 and held it in 3 quarters.
  • Tobias Financial Advisors's TherapeuticsMD position peaked at $12K in Q3 2021.
  • 53 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2022.

Based on Tobias Financial Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.